Analysts had expected a loss of US$753 million, or US$1.90 a share, according to LSEG data. Its Spikevax Covid vaccine brought in sales of US$1.8 billion, up 3.5 per cent over the previous year and ...

Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial.

which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax. British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in ...

The suits allege that nanoparticles used in Moderna's Spikevax COVID-19 shot and recently approved mResvia vaccine for RSV – which competes with GSK's $1.7 billion blockbuster Arexvy ...

Integrating EBP into your nursing practice improves quality of care and patient ... Poster and podium presentation templates are available in our Inquiry Toolkit. To learn more about sharing your ...

Some of the best toothache medicines are not necessarily found on drugstore shelves. Although over-the-counter (OTC) painkillers and topical anesthetics can be very effective at easing toothache pain, ...